title: Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.
authors.affiliation: Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Mannheim, Germany.
authors.forename: Rick
authors.initials: R
authors.lastname: Proschmann
authors.affiliation: Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Mannheim, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Baldow
authors.affiliation: Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Mannheim, Germany.
authors.forename: Tino
authors.initials: T
authors.lastname: Rothe
authors.affiliation: Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital "Carl Gustav Carus", Technische Universität Dresden, Mannheim, Germany.
authors.forename: Meinolf
authors.initials: M
authors.lastname: Suttorp
authors.affiliation: Department of Internal Medicine, Medical Clinic I, University Hospital "Carl Gustav Carus", Technische Universität Dresden, Mannheim, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Thiede
authors.affiliation: Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital "Carl Gustav Carus", Technische Universität Dresden, Mannheim, Germany.
authors.forename: Josephine T
authors.initials: JT
authors.lastname: Tauer
authors.affiliation: Department of Internal Medicine, Medical Clinic III, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany.
authors.forename: Martin C
authors.initials: MC
authors.lastname: Müller
authors.affiliation: Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Hochhaus
authors.affiliation: Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Mannheim, Germany.|National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany.
authors.forename: Ingo
authors.initials: I
authors.lastname: Roeder
authors.affiliation: Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Mannheim, Germany ingmar.glauche@tu-dresden.de.
authors.forename: Ingmar
authors.initials: I
authors.lastname: Glauche
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D015870:Gene Expression; D005858:Germany; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D007223:Infant; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; C581634:BCR-ABL1 fusion protein, human; D047428:Protein Kinase Inhibitors; D012333:RNA, Messenger; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl